Logo image of TNON

TENON MEDICAL INC (TNON) Stock Fundamental Analysis

NASDAQ:TNON - Nasdaq - US88066N3035 - Common Stock - Currency: USD

1.12  0 (0%)

After market: 1.1 -0.02 (-1.79%)

Fundamental Rating

3

TNON gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 191 industry peers in the Health Care Equipment & Supplies industry. The financial health of TNON is average, but there are quite some concerns on its profitability. TNON is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year TNON has reported negative net income.
In the past year TNON has reported a negative cash flow from operations.
TNON had negative earnings in each of the past 5 years.
In the past 5 years TNON always reported negative operating cash flow.
TNON Yearly Net Income VS EBIT VS OCF VS FCFTNON Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

TNON has a worse Return On Assets (-138.91%) than 86.91% of its industry peers.
TNON's Return On Equity of -228.99% is on the low side compared to the rest of the industry. TNON is outperformed by 76.44% of its industry peers.
Industry RankSector Rank
ROA -138.91%
ROE -228.99%
ROIC N/A
ROA(3y)-185.03%
ROA(5y)-156.48%
ROE(3y)-844.8%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TNON Yearly ROA, ROE, ROICTNON Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

1.3 Margins

The Gross Margin of TNON (52.21%) is comparable to the rest of the industry.
TNON's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for TNON so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 52.21%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.76%
GM growth 5Y-8.18%
TNON Yearly Profit, Operating, Gross MarginsTNON Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K -4K

More info and screens

6

2. Health

2.1 Basic Checks

TNON does not have a ROIC to compare to the WACC, probably because it is not profitable.
TNON has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, TNON has more shares outstanding
There is no outstanding debt for TNON. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
TNON Yearly Shares OutstandingTNON Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 1M 2M 3M
TNON Yearly Total Debt VS Total AssetsTNON Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

TNON has an Altman-Z score of -12.21. This is a bad value and indicates that TNON is not financially healthy and even has some risk of bankruptcy.
TNON has a worse Altman-Z score (-12.21) than 79.58% of its industry peers.
TNON has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -12.21
ROIC/WACCN/A
WACC8.97%
TNON Yearly LT Debt VS Equity VS FCFTNON Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 5M -5M -10M

2.3 Liquidity

TNON has a Current Ratio of 4.39. This indicates that TNON is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of TNON (4.39) is better than 71.73% of its industry peers.
TNON has a Quick Ratio of 4.07. This indicates that TNON is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 4.07, TNON is in the better half of the industry, outperforming 72.77% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.39
Quick Ratio 4.07
TNON Yearly Current Assets VS Current LiabilitesTNON Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 68.78% over the past year.
Looking at the last year, TNON shows a quite strong growth in Revenue. The Revenue has grown by 12.15% in the last year.
TNON shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 130.83% yearly.
EPS 1Y (TTM)68.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%53.31%
Revenue 1Y (TTM)12.15%
Revenue growth 3Y173.6%
Revenue growth 5Y130.83%
Sales Q2Q%-4.7%

3.2 Future

Based on estimates for the next years, TNON will show a very strong growth in Earnings Per Share. The EPS will grow by 25.42% on average per year.
Based on estimates for the next years, TNON will show a very strong growth in Revenue. The Revenue will grow by 47.04% on average per year.
EPS Next Y85.21%
EPS Next 2Y39.71%
EPS Next 3Y25.42%
EPS Next 5YN/A
Revenue Next Year89.23%
Revenue Next 2Y47.04%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
TNON Yearly Revenue VS EstimatesTNON Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2M 4M 6M 8M
TNON Yearly EPS VS EstimatesTNON Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 -50 -100 -150

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

TNON reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year TNON is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TNON Price Earnings VS Forward Price EarningsTNON Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TNON Per share dataTNON EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10 -15 -20

4.3 Compensation for Growth

A more expensive valuation may be justified as TNON's earnings are expected to grow with 25.42% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.71%
EPS Next 3Y25.42%

More info and screens

0

5. Dividend

5.1 Amount

TNON does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TENON MEDICAL INC

NASDAQ:TNON (4/21/2025, 8:00:01 PM)

After market: 1.1 -0.02 (-1.79%)

1.12

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-20 2025-03-20/amc
Earnings (Next)05-12 2025-05-12/amc
Inst Owners4.19%
Inst Owner Change0%
Ins Owners0.63%
Ins Owner Change0%
Market Cap6.94M
Analysts82.5
Price Target7.65 (583.04%)
Short Float %5.38%
Short Ratio0.15
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.96%
Min EPS beat(2)1.96%
Max EPS beat(2)15.97%
EPS beat(4)4
Avg EPS beat(4)8.58%
Min EPS beat(4)1.96%
Max EPS beat(4)15.97%
EPS beat(8)7
Avg EPS beat(8)16.98%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-37.45%
Min Revenue beat(2)-47.97%
Max Revenue beat(2)-26.94%
Revenue beat(4)0
Avg Revenue beat(4)-21.94%
Min Revenue beat(4)-47.97%
Max Revenue beat(4)-2.88%
Revenue beat(8)0
Avg Revenue beat(8)-20.17%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-25%
PT rev (3m)-25%
EPS NQ rev (1m)59.71%
EPS NQ rev (3m)59.71%
EPS NY rev (1m)55.22%
EPS NY rev (3m)55.22%
Revenue NQ rev (1m)-18.3%
Revenue NQ rev (3m)-18.3%
Revenue NY rev (1m)-5.52%
Revenue NY rev (3m)-5.52%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.12
P/FCF N/A
P/OCF N/A
P/B 1.16
P/tB 1.16
EV/EBITDA N/A
EPS(TTM)-24.33
EYN/A
EPS(NY)-3.6
Fwd EYN/A
FCF(TTM)-1.62
FCFYN/A
OCF(TTM)-1.59
OCFYN/A
SpS0.53
BVpS0.96
TBVpS0.96
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -138.91%
ROE -228.99%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 52.21%
FCFM N/A
ROA(3y)-185.03%
ROA(5y)-156.48%
ROE(3y)-844.8%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.76%
GM growth 5Y-8.18%
F-Score5
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 28.4%
Cap/Sales 5.68%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.39
Quick Ratio 4.07
Altman-Z -12.21
F-Score5
WACC8.97%
ROIC/WACCN/A
Cap/Depr(3y)391.88%
Cap/Depr(5y)N/A
Cap/Sales(3y)47.06%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)68.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%53.31%
EPS Next Y85.21%
EPS Next 2Y39.71%
EPS Next 3Y25.42%
EPS Next 5YN/A
Revenue 1Y (TTM)12.15%
Revenue growth 3Y173.6%
Revenue growth 5Y130.83%
Sales Q2Q%-4.7%
Revenue Next Year89.23%
Revenue Next 2Y47.04%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y12.48%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y19.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y18.92%
OCF growth 3YN/A
OCF growth 5YN/A